Related Experiment Video
Updated: Mar 23, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Generalized Intense Pruritus During Canagliflozin Treatment: Is it an Adverse Drug Reaction?
Piero Vasapollo1, Erika Cione2, Filippo Luciani3
1Department of General and Territorial Medicine, Azienda Sanitaria Provinciale, Crotone, Italy.
Background:
Selective agents able to locate and identify unique targets represent a crucial aspect of modern pharmacology. The exclusive location of Sodium-Glucose co-Transporter-2 (SGLUT2) on kidneys prompt companies to develop SGLT2 inhibitors that today are the latest class of drugs for diabetes treatment. In particular, canagliflozin blocks the re-absorption of glucose in the kidney lowering blood glucose levels by increasing glucose excretion.
Case Description:
We report a 61-year old woman who developed an intense and severe pruritus during the treatment with canagliflozin. Clinical and laboratory findings excluded the presence of systemic or skin diseases able to induce pruritus. The discontinuation of canagliflozin and the treatment with pioglitazone/metformin fixed combination induced a remission of pruritus.
Conclusion:
This case emphasizes the need to consider pruritus as a differential diagnosis during the treatment with canagliflozin.
Related Concept Videos
Allergic Drug Reactions
Nephrotic Syndrome I : Introduction
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Oral Hypoglycemic Agents: Biguanides and Glitazones
Nephrotic Syndrome III : Nursing Management
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

